Tushar Srivastava

4PUBLICATIONS
19CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsWastewater treatment processesEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 02, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.

Sue Harnan, Ben Kearns, Alison Scope

|Jun 28, 2024
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.

Beth Woods, Laetitia Schmitt, Dina Jankovic

|May 19, 2021
Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals.

Tushar Srivastava, Nicholas R Latimer, Paul Tappenden

|Nov 03, 2020
Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia.

Masnoon Saiyed, Joshua Byrnes, Tushar Srivastava

Pageof 1

Frequent Collaborators

2 joint publications

Jean Hamilton

2 joint publications

Claire Rothery

2 joint publications

Chu Chang Ku

2 joint publications

Laura Bojke